These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Specificity of DNA alkylation by 1-(2-chloroethyl)-3-alkyl-3-acyltriazenes depends on the structure of the acyl group: kinetic and product studies. Smith MB; Schmidt BF; Czerwinski G; Taneyhill LA; Snyder EJ; Kline AM; Michejda CJ; Smith RH Chem Res Toxicol; 1996 Mar; 9(2):466-75. PubMed ID: 8839051 [TBL] [Abstract][Full Text] [Related]
3. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33). Lin CW; Holladay MW; Barrett RW; Wolfram CA; Miller TR; Witte D; Kerwin JF; Wagenaar F; Nadzan AM Mol Pharmacol; 1989 Dec; 36(6):881-6. PubMed ID: 2601685 [TBL] [Abstract][Full Text] [Related]
4. 1,3-Dialkyl-3-acyltriazenes, a novel class of antineoplastic alkylating agents. Smith RH; Scudiero DA; Michejda CJ J Med Chem; 1990 Sep; 33(9):2579-83. PubMed ID: 2391696 [TBL] [Abstract][Full Text] [Related]
5. An unexpected pathway for the metabolic degradation of 1,3-dialkyl-3-acyltriazenes. Rouzer CA; Thompson EJ; Skinner TL; Heavner PA; Bartolini WP; Mitchell K; Kurz E; Smith RH; Michejda CJ Biochem Pharmacol; 1993 Jul; 46(1):165-73. PubMed ID: 8347127 [TBL] [Abstract][Full Text] [Related]
6. The use of receptor desensitization to analyse CCKA and CCKB/gastrin receptors coupled to contraction in guinea-pig stomach muscle. Bishop LA; Gerskowitch VP; Hull RA; Shankley NP; Black JW Br J Pharmacol; 1995 Jan; 114(2):339-48. PubMed ID: 7881733 [TBL] [Abstract][Full Text] [Related]
7. Cytotoxic agents directed to peptide hormone receptors: defining the requirements for a successful drug. Czerwinski G; Tarasova NI; Michejda CJ Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11520-5. PubMed ID: 9751698 [TBL] [Abstract][Full Text] [Related]
8. Anticancer Triazenes: from Bioprecursors to Hybrid Molecules. Francisco AP; Mendes E; Santos AR; Perry MJ Curr Pharm Des; 2019; 25(14):1623-1642. PubMed ID: 31244412 [TBL] [Abstract][Full Text] [Related]
9. A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260. Lotti VJ; Chang RS Eur J Pharmacol; 1989 Mar; 162(2):273-80. PubMed ID: 2721567 [TBL] [Abstract][Full Text] [Related]
10. Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential. Behr TM; Béhé M; Angerstein C; Gratz S; Mach R; Hagemann L; Jenner N; Stiehler M; Frank-Raue K; Raue F; Becker W Clin Cancer Res; 1999 Oct; 5(10 Suppl):3124s-3138s. PubMed ID: 10541353 [TBL] [Abstract][Full Text] [Related]
11. Analysis of the variation in the action of L-365,260 at CCKB/gastrin receptors in rat, guinea-pig and mouse isolated gastric tissue assays. Roberts SP; Harper EA; Watt GF; Gerskowitch VP; Hull RA; Shankley NP; Black JW Br J Pharmacol; 1996 Aug; 118(7):1779-89. PubMed ID: 8842444 [TBL] [Abstract][Full Text] [Related]
12. Cholecystokinin and gastrin induce cell contraction in pig ileum by interacting with different receptor subtypes. Botella A; Delvaux M; Berry P; Frexinos J; Bueno L Gastroenterology; 1992 Mar; 102(3):779-86. PubMed ID: 1537515 [TBL] [Abstract][Full Text] [Related]
13. Glycine-extended gastrin exerts growth-promoting effects on human colon cancer cells. Stepan VM; Sawada M; Todisco A; Dickinson CJ Mol Med; 1999 Mar; 5(3):147-59. PubMed ID: 10404512 [TBL] [Abstract][Full Text] [Related]
14. CCK-8, CCK-4 and gastrin-induced contractions in guinea pig ileum: evidence for differential release of acetylcholine and substance P by CCK-A and CCK-B receptors. Lucaites VL; Mendelsohn LG; Mason NR; Cohen ML J Pharmacol Exp Ther; 1991 Feb; 256(2):695-703. PubMed ID: 1704435 [TBL] [Abstract][Full Text] [Related]
15. Base sequence selectivity in the alkylation of DNA by 1,3-dialkyl-3-acyltriazenes. Kroeger Smith MB; Taneyhill LA; Michejda CJ; Smith RH Chem Res Toxicol; 1996; 9(1):341-8. PubMed ID: 8924614 [TBL] [Abstract][Full Text] [Related]
16. Antiproliferative effect of a novel cholecystokinin-B/gastrin receptor antagonist, YM022. Murayama T; Matsumori Y; Iwata N; Ito M; Taniguchi T; Chihara K; Matsui T Jpn J Cancer Res; 1996 Jul; 87(7):743-50. PubMed ID: 8698625 [TBL] [Abstract][Full Text] [Related]
17. Alkylation of DNA by 1,3-dialkyl-3-acyltriazenes: correlation of biological activity with chemical behavior. Kroeger-Koepke MB; Michejda CJ; Smith RH Chem Res Toxicol; 1992; 5(4):541-7. PubMed ID: 1391620 [TBL] [Abstract][Full Text] [Related]
18. Evidence for autocrine growth stimulation of cultured colon tumor cells by a gastrin/cholecystokinin-like peptide. Hoosein NM; Kiener PA; Curry RC; Brattain MG Exp Cell Res; 1990 Jan; 186(1):15-21. PubMed ID: 2298233 [TBL] [Abstract][Full Text] [Related]